Genprex Inc (GNPX)

Apr 15, 2026

Genprex director Longnecker sells shares worth $22 - Investing.com

Apr 15, 2026

Apr 15, 2026

Genprex director Longnecker sells shares worth $22 By Investing.com - Investing.com South Africa

Apr 15, 2026

Apr 15, 2026

Genprex (GNPX) director logs small stock sales mainly for taxes - Stock Titan

Apr 15, 2026

Apr 13, 2026

GNPX Technical Analysis | Trend, Signals & Chart Patterns | GENPREX INC (NASDAQ:GNPX) - ChartMill

Apr 13, 2026

Apr 11, 2026

Surprises Report: What are the analyst revisions for Guess IncIs Genprex Inc stock a good investment in YEARWeekly Stock Analysis & Expert Approved Momentum Trade Ideas - baoquankhu1.vn

Apr 11, 2026

Apr 10, 2026

GNPX Should I Buy - Intellectia AI

Apr 10, 2026

Apr 08, 2026

US Stocks Recap: What is the PEG ratio of AXSM2026 WrapUp & Risk Adjusted Buy/Sell Alerts - baoquankhu1.vn

Apr 08, 2026

Apr 02, 2026

Genprex Shares Hit Annual Low Despite Stronger-Than-Expected Earnings - AD HOC NEWS

Apr 02, 2026

Apr 01, 2026

GNPX SEC FilingsGenprex Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Apr 01, 2026

Mar 30, 2026

Genprex (NASDAQ: GNPX) advances REQORSA trials, eyes diabetes gene therapy - Stock Titan

Mar 30, 2026

Mar 30, 2026

Genprex, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com

Mar 30, 2026

Mar 30, 2026

Published on: 2026-03-30 13:10:35 - baoquankhu1.vn

Mar 30, 2026

Mar 29, 2026

Genprex, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com

Mar 29, 2026

Mar 27, 2026

Top Ranking Stock Picker From Congress Is Back Buying Small Cap Stocks Again: Here Are The Tickers - Benzinga

Mar 27, 2026

Mar 26, 2026

IPO Launch: Whats the beta of Genprex Inc stock2026 Drop Watch & AI Powered Buy and Sell Recommendations - baoquankhu1.vn

Mar 26, 2026

Mar 25, 2026

Dip Buying: Will Genprex Inc benefit from green energy policiesQuarterly Profit Review & Free Long-Term Investment Growth Plans - baoquankhu1.vn

Mar 25, 2026

Mar 24, 2026

GNPX Stock Chart | GENPREX INC (NASDAQ:GNPX) - ChartMill

Mar 24, 2026

Mar 22, 2026

Performance Recap: What are the analyst revisions for Guess IncIs Genprex Inc stock a good investment in YEAR2026 Selloffs & Weekly Chart Analysis and Guides - baoquankhu1.vn

Mar 22, 2026

Mar 20, 2026

Genprex, Inc.: Fundamental Analysis and Financial Ratings | 2DE | US3724463027 - marketscreener.com

Mar 20, 2026

Mar 20, 2026

GNPX Earnings History & Surprises | EPS & Revenue Results | GENPREX INC (NASDAQ:GNPX) - ChartMill

Mar 20, 2026

Mar 19, 2026

Genprex Collaborators to Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Lung Cancer at the 2026 AACR Annual Meeting - BioSpace

Mar 19, 2026

Mar 19, 2026

Genprex collaborators to present lung cancer data at AACR meeting By Investing.com - Investing.com Australia

Mar 19, 2026

Mar 18, 2026

Genprex presents positive preclinical REQORSA data at AACR showing biomarkers and combo efficacy - TradingView

Mar 18, 2026

Mar 18, 2026

Genprex Highlights New Reqorsa Preclinical Data at AACR - TipRanks

Mar 18, 2026

Mar 18, 2026

GNPX: Genprex Researchers to Present at AACR 2026 with Promising Lung Cancer Data - GuruFocus

Mar 18, 2026

Mar 18, 2026

Genprex collaborators to present lung cancer data at AACR meeting - Investing.com

Mar 18, 2026

Mar 18, 2026

Genprex (NASDAQ: GNPX) posts positive preclinical data on REQORSA in NSCLC - Stock Titan

Mar 18, 2026

Mar 13, 2026

New Highs: Will Genprex Inc benefit from green energy policiesTrade Risk Assessment & Free Low Drawdown Momentum Trade Ideas - baoquankhu1.vn

Mar 13, 2026

Mar 10, 2026

Genprex to Participate at BIO Europe Spring 2026 - GuruFocus

Mar 10, 2026

Mar 10, 2026

GNPX Stock News Today | Earnings, Events & Price Alerts - Intellectia AI

Mar 10, 2026

Mar 06, 2026

Aug Closing: Will Genprex Inc outperform tech stocksMarket Activity Report & Weekly High Return Forecasts - baoquankhu1.vn

Mar 06, 2026

Mar 06, 2026

Trend Recap: Will Genprex Inc outperform tech stocksWeekly Gains Report & Technical Confirmation Trade Alerts - baoquankhu1.vn

Mar 06, 2026

Mar 01, 2026

Genprex receives patent approval in Australia for cancer therapy - Investing.com Nigeria

Mar 01, 2026

Feb 28, 2026

Congressman Who Bought Small-Cap Stocks In 2025 Is Back With New 2026 Pick: Here's What He's Buying - Yahoo Finance

Feb 28, 2026

Feb 28, 2026

GNPX Earning Date, Earning Analysis and Earning Prediction - Intellectia AI

Feb 28, 2026

Feb 27, 2026

Genprex (NASDAQ: GNPX) CMO has shares withheld to cover RSU taxes - Stock Titan

Feb 27, 2026

Feb 27, 2026

Genprex (GNPX) CEO reports 9,330-share tax-withholding disposition - Stock Titan

Feb 27, 2026

Feb 26, 2026

Congressional Trading Activity Insights - Intellectia AI

Feb 26, 2026

Feb 26, 2026

Genprex bags major patent wins in Japan & Europe for REQORSA cancer therapy - Indian Pharma Post

Feb 26, 2026

Feb 25, 2026

Genprex Advances Cancer Therapy Strategy with Key International Patents - AD HOC NEWS

Feb 25, 2026

Feb 24, 2026

Genprex receives Japanese and European patents for cancer therapy By Investing.com - Investing.com India

Feb 24, 2026

Feb 23, 2026

Genprex stock jumps on Japan, Europe patent approvals By Investing.com - Investing.com Nigeria

Feb 23, 2026

Feb 23, 2026

Genprex stock jumps on Japan, Europe patent approvals - Investing.com

Feb 23, 2026

Feb 23, 2026

12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga

Feb 23, 2026

Feb 23, 2026

GENPREX, INC.COMMON STOCKTim Moore Congressional Trade on Feb. 05, 2026 - Quiver Quantitative

Feb 23, 2026

Feb 23, 2026

Genprex (GNPX) Gains Global Patent Approvals for Innovative Canc - GuruFocus

Feb 23, 2026

Feb 23, 2026

Genprex Secures Key Global Patents for REQORSA Therapy - TipRanks

Feb 23, 2026

Feb 23, 2026

Genprex receives Japanese and European patents for cancer therapy - Investing.com

Feb 23, 2026

Feb 23, 2026

Genprex secures Japan, EU patents for REQORSA combos, bolstering Acclaim-3 IP and trial - TradingView

Feb 23, 2026